Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Douxfils

Showing results (51-60 of 221) with videos related to

Pageof 23
Sort By:
Research and Practice in Thrombosis and Haemostasis|May 31, 2023
Hormonal therapies and venous thrombosis: considerations for prevention and management-a reappraisalJonathan Douxfils, Laure Morimont, Mitchell D Creinin, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptivesLaure Morimont, Mitchell D Creinin, Ulysse Gaspard, et al.
Journal of Thrombosis and Haemostasis : JTH|January 28, 2020
Proof of concept of a new scale for the harmonization and the standardization of the ETP-based APC resistanceLaure Morimont, Céline Bouvy, Anne-Sophie Delvigne, et al.
The Annals of Pharmacotherapy|December 20, 2014
Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' replyAnne-Sophie Larock, François Mullier, Jonathan Douxfils, et al.
Thrombosis Research|September 21, 2022
Estetrol is not a SERM but a NEST and has a specific safety profile on coagulationJonathan Douxfils, Laure Morimont, Ulysse Gaspard, et al.
The Journal of Infection|January 25, 2022
Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severityJulien Favresse, Jean-Louis Bayart, Clara David, et al.
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Hormonal therapies and venous thrombosis: Estrogen matters!Laure Morimont, Mitchell D Creinin, Ulysse Gaspard, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2021
Influence of C-reactive protein on thrombin generation assayMarie Didembourg, Jonathan Douxfils, François Mullier, et al.
Thrombosis Research|October 15, 2018
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generationSaartje Bloemen, Suzanne Zwaveling, Jonathan Douxfils, et al.
International Journal of Laboratory Hematology|November 16, 2021
Effect of tissue factor pathway inhibitor on thrombin generation assayMarie Didembourg, Jonathan Douxfils, Audrey Carlo, et al.
Pageof 23

Showing results (51-60 of 221) with videos related to

Sort By:
Pageof 23
Research and Practice in Thrombosis and Haemostasis|May 31, 2023
Hormonal therapies and venous thrombosis: considerations for prevention and management-a reappraisalJonathan Douxfils, Laure Morimont, Mitchell D Creinin, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptivesLaure Morimont, Mitchell D Creinin, Ulysse Gaspard, et al.
Journal of Thrombosis and Haemostasis : JTH|January 28, 2020
Proof of concept of a new scale for the harmonization and the standardization of the ETP-based APC resistanceLaure Morimont, Céline Bouvy, Anne-Sophie Delvigne, et al.
The Annals of Pharmacotherapy|December 20, 2014
Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' replyAnne-Sophie Larock, François Mullier, Jonathan Douxfils, et al.
Thrombosis Research|September 21, 2022
Estetrol is not a SERM but a NEST and has a specific safety profile on coagulationJonathan Douxfils, Laure Morimont, Ulysse Gaspard, et al.
The Journal of Infection|January 25, 2022
Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severityJulien Favresse, Jean-Louis Bayart, Clara David, et al.
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Hormonal therapies and venous thrombosis: Estrogen matters!Laure Morimont, Mitchell D Creinin, Ulysse Gaspard, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2021
Influence of C-reactive protein on thrombin generation assayMarie Didembourg, Jonathan Douxfils, François Mullier, et al.
Thrombosis Research|October 15, 2018
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generationSaartje Bloemen, Suzanne Zwaveling, Jonathan Douxfils, et al.
International Journal of Laboratory Hematology|November 16, 2021
Effect of tissue factor pathway inhibitor on thrombin generation assayMarie Didembourg, Jonathan Douxfils, Audrey Carlo, et al.
Pageof 23